Superior Cr And Event-Free (Efs) But Not Overall Survival (Os) On Thalidomide (Thal) Arm Of Tandem Transplant-Based Total Therapy 2 (Tt2) For Myeloma (Mm): Results Of A Phase Iii Trial With Prognostic Factors (Pr).
JOURNAL OF CLINICAL ONCOLOGY（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要